CU Innovations

Excited to share that OncoVerity has secured additional funding to advance our mission of transforming hope into reality for cancer patients. Our Phase 2 trial evaluating cusatuzumab is officially underway and has enrolled its first patients! https://lnkd.in/gBj3K3yC

At tonight’s 21st Annual Awards Celebration Presented by AGC Biologics, CBSA honored Steven VanNurden, Associate Vice Chancellor of Biotechnology at the University of Colorado Anschutz Medical Campus and President & CEO of Fitzsimons Innovation Community, with the Lifetime Achievement Award for his pioneering contributions to Colorado’s life sciences landscape. His career has been marked by his leadership in transforming academic discoveries into life-saving products and his impact in expanding innovation infrastructure for Colorado’s life sciences companies. Our community celebrates Steve for his vision, passion, and commitment to patients! #COBioScience #StrongerTogether #AllIn

We’re excited to officially launch Jupiter Bioventures, a pioneering biotechnology venture foundry building bold, science-driven therapeutics companies. Co-Founders Nathaniel David, PhD, and Norman Sharpless, MD, bring decades of industry experience to drive a scalable foundry model, advancing #biotech innovation in #cancer and other areas in which insights from cancer biology provide insight. With $70 million raised from returning investors Mission BioCapital and Mayo Clinic alongside #lifescience investors Alexandria Venture Investments, Bioventure Partners, Cedars-Sinai Intellectual Property Company, CU Healthcare Innovation Fund, Eric Ball, Eshelman Ventures, LLC, Fox Ventures, The Brent and Julie Callinicos Trust and Vault Fund, Jupiter will found, launch, and operate multiple therapeutics companies. https://lnkd.in/eaUJsaE8 Stay tuned as we pursue breakthrough science to deliver #innovation in life sciences.

“We were born out of this University, and we continue to have extremely strong ties to it. We’ve obviously evolved and now have our own identity, too, but we’ve learned that bringing the best of academia and the best of industry together can create the best company, so we never want to lose that connection.”   Erik Johnson, CEO, RefinedScience    Read the announcement: https://lnkd.in/ekG8tk7H   Read our recent blog post: https://lnkd.in/ehPkrX3M

We are thrilled to introduce our distinguished judges for the 2024 Fire Pitch Competition! Allison Rhines – Head of JLABS, Houston Andrew Truscott – Global Health Technology Lead, Accenture Angela Shippy MD – Sr. Physician Executive, Amazon Web Services (AWS) Kimberly Muller – Executive Director, CU Innovations, University of Colorado Anschutz Medical Campus Myra Davis – Chief Innovation and Information Officer, Texas Children's Hospital Winjie Tang Miao – SEVP and Chief Operating Officer, Texas Health Resources Join us as the top startups from the 2024 Ignite accelerator take the stage to pitch in front of investors, partners, and industry leaders—competing for prestigious awards and prizes that will help propel their businesses to the next level. 🎟️ Don’t miss out! Register now to witness innovation in action: https://lnkd.in/eBnETXe6 #FirePitchCompetition #Entrepreneurship #HealthcareInnovation #Ignite #HoustonEvents #Innovation #Startups

Congratulations to V. Michael Holers, MD, recipient of the 2024 Presidential Gold Medal Award! Dr. Holers is the Smyth Professor of Rheumatology and past Division Head of Rheumatology at the University of Colorado Anschutz Medical Campus in Aurora, Colorado, as well as the Immediate Past President of the Rheumatology Research Foundation. #ACR24

Congratulations to Kristi Kuhn, MD, PhD, recipient of the 2024 Henry Kunkel Early Career Investigator Award! Dr. Kuhn is the Scoville Endowed Chair and Head of the Division of Rheumatology and a Professor of Medicine and of Immunology and Microbiology at the University of Colorado Anschutz Medical Campus in Aurora, Colorado. #ACR24